New therapeutic opportunities for 5-HT2 receptor ligands.

Maroteaux L, Ayme-Dietrich E, Aubertin-Kirch G, Banas S, Quentin E, Lawson R, Monassier L.

Pharmacol Ther. 2017 Feb;170:14-36.